ACN Newswire
Read More

EC Healthcare Expects Third Quarter FY23 Sales Volume to Increase no less than 8% YoY

indie
4 minutes

HONG KONG, Jan 20, 2023 - (ACN Newswire via SEAPRWire.com) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Group expects sales volume for the period of October to December 2022 (the "Quarter") to increase by no less than 8% as compared with the same period last year.The demand on medical services provided by the Group remains strong and the Group's increasingly diversified business demonstrated resilience and good momentum. The Board expects to record overall sales volume of no less than HK$1,000 million for the Quarter, representing a no less than 8% YoY increase. The Group expects to achieve a no less than 39% YoY increase for medical services sales volume. Sales volume of aesthetic medical and beauty and wellness services in Hong Kong and Macau declined by no more than 17% YoY, while sales volume of aesthetic medical and beauty and wellness services in Mainland China declined by no more than 50% YoY during the Quarter. The decrease in aesthetic medical and beauty and wellness services was mainly due to (i) weaker local ...

ACN Newswire

Perfect Medical Announces Interim Results for FY2022/23

indie
5 minutes

HONG KONG, Nov 23, 2022 - (ACN Newswire via SEAPRWire.com) - Perfect Medical Health Management Limited (the "Company" , Stock Code: 1830.HK), one of the largest aesthetic medical operators in the world, together with its subsidiaries (collectively referred to as the "Group"), is pleased to announce its interim results for the six months ended 30 September 2022.RESULTS HIGHLIGHTS-- The Group's revenue decreased by 16.6% to HK$668.3 million, impacted by Covid-19 pandemic causing suspension of 20 days in Hong Kong, 39 days in Macau, as well a business disruption for an average of 14 days, 23 days, 63 days and 19 days across Guangzhou, Shenzhen, Shanghai and Beijing respectively.-- The second quarter marked a 52.1% growth in revenue quarter-on-quarter in Hong Kong following the ease of Covid-19 pandemic.-- The Group's EBITDA decreased by 25.5% to HK$229.7 million.-- The Group's net profit decreased by 30.4% to HK$150.7 million, representing the net profit margin of 22.5%. Basic earnings per share was HK12.1 cents.-- The Board recommends the payment of an interim dividend of HK13.0 cents per share, representing a dividend payout ratio of 107.4%.-- The Group operated a total of 307,000 s...

ACN Newswire

Perfect Medical Announces Final Results for FY2021/22

indie
5 minutes

HONG KONG, Jul 4, 2022 - (ACN Newswire via SEAPRWire.com) - Perfect Medical Health Management Limited ("Perfect Medical" or the "Company", stock code: 1830.HK), one of the largest medical groups in Hong Kong, together with its subsidiaries (collectively referred to as the "Group"), is pleased to announce its annual results for the year ended 31 March 2022.Performance highlights-- The Company achieved a historical high revenue of HK$1.35 billion, representing a growth of 23.9%.-- Among the value of sales contract, aesthetic medical accounted for 66.0%, medical business accounted for 17.4% and beauty and wellness accounted for 16.6%.-- The Company achieved a satisfactory net profit of HK$305.2 million despite the impact of the pandemic. If excluding the government subsidies, the revised net profit after tax increased by 29.8%.-- The Company has expanded its geographical coverage to Hong Kong, China, Australia and Singapore, representing total service area increased by 39.0% to 322,000 sq.ft..-- Basic earnings per share increased by 2.1% to HK24.8 cents.-- To reward the shareholders' unwavering support, the Board recommended the payment of a final dividend of HK7.1 cents per share. To...

ACN Newswire
Read More

Sihuan Pharmaceutical(0460.HK): Respond to the special directives to combat illegal medical aesthetics services, Advocate ‘Positive Energy’ of China’s Medical Aesthetics Industry

indie
4 minutes

HONG KONG, Aug 11, 2021 - (ACN Newswire via SEAPRWire.com) - On June 10, 2021, the National Health Commission, leading eight ministries and commissions, issued the "Notice on Distributing the Special Rectification Work Plan for Combating Illegal Medical Aesthetic Services." On August 9, 2021, 'The People's Daily' published an article entitled - 'Medical aesthetic sector needs to achieve best effects and prevent adverse consequences.' The article highlighted the current rectification plan in the medical aesthetic sector is to establish high industry standards, strengthen supervision, and crack down on illegal medical aesthetic services in order to create a clean and reliable medical aesthetic environment. This plan will foster new advances in medical aesthetic industry and encourage the sector's healthy development.The imported product - Letybo (botulinum toxin type A for Injection) is a medical aesthetic product produced by South Korea's Hugel Inc. Bain Capital, a well-known international private equity fund, is the controlling shareholder of Hugel Inc in South Korea. Beijing Meiyan Space Biomedicine Co., Ltd., a subsidiary of Sihuan Pharmaceutical, serves as the product's exclusiv...

ACN Newswire
Read More

Strategic Collaboration Memorandum between EC Healthcare and China Medical System Utilizes the Synergy of Upstream and Downstream of the Aesthetic Medical Industry, Promotes the Development of Medical Products and Talents

indie
6 minutes

HONG KONG, Jun 11, 2021 - (ACN Newswire via SEAPRWire.com) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong* and China Medical System Holdings Limited (the "CMS", SEHK stock code: 867), jointly announce that the Group and a subsidiary of the CMS entered into a memorandum in relation to the strategiccollaboration, including but not limited to setting up an aesthetic medical marketing centre for distribution and marketing of aesthetics medication and related products initially in Hong Kong , and exploring to set up an aesthetic medical training and education platform for registered practitioners, and further exploring the formation of a nationwide aesthetic medical doctor partnership business platform.The Group is the largest non-hospital medical service provider in Hong Kong based in the Greater Bay Area, providing medical, aesthetic medical and healthcare services. The CMS Group is an innovation-driven specialty pharma with a focus on sales and marketing in China, with more than two decades proven record of experience in successful drug promotion in multi d...

ACN Newswire
Read More

Strategic collaboration Memorandum between EC Healthcare and China Medical System Utilize the Synergy of Upstream and Downstream of the Aesthetic Medical Industry, Jointly Promote the Development of Medical Products and Talents

indie
6 minutes

HONG KONG, Jun 11, 2021 - (ACN Newswire via SEAPRWire.com) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong* and China Medical System Holdings Limited (the "CMS", SEHK stock code: 867), jointly announce that the Group and a subsidiary of the CMS entered into a memorandum in relation to the strategiccollaboration, including but not limited to setting up an aesthetic medical marketing centre for distribution and marketing of aesthetics medication and related products initially in Hong Kong , and exploring to set up an aesthetic medical training and education platform for registered practitioners, and further exploring the formation of a nationwide aesthetic medical doctor partnership business platform.The Group is the largest non-hospital medical service provider in Hong Kong based in the Greater Bay Area, providing medical, aesthetic medical and healthcare services. The CMS Group is an innovation-driven specialty pharma with a focus on sales and marketing in China, with more than two decades proven record of experience in successful drug promotion in multi d...

ACN Newswire
Read More

Strategic collaboration Memorandum between EC Healthcare and China Medical System

indie
6 minutes

HONG KONG, Jun 11, 2021 - (ACN Newswire via SEAPRWire.com) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong* and China Medical System Holdings Limited (the "CMS", SEHK stock code: 867), jointly announce that the Group and a subsidiary of the CMS entered into a memorandum in relation to the strategiccollaboration, including but not limited to setting up an aesthetic medical marketing centre for distribution and marketing of aesthetics medication and related products initially in Hong Kong , and exploring to set up an aesthetic medical training and education platform for registered practitioners, and further exploring the formation of a nationwide aesthetic medical doctor partnership business platform.The Group is the largest non-hospital medical service provider in Hong Kong based in the Greater Bay Area, providing medical, aesthetic medical and healthcare services. The CMS Group is an innovation-driven specialty pharma with a focus on sales and marketing in China, with more than two decades proven record of experience in successful drug promotion in multi d...

ACN Newswire
Read More

China Medical System (00867) Ushers in a Revaluation with its Continuous Growth and Synergy between Innovative Business and New Businesses

indie
13 minutes

HONG KONG, Mar 30, 2021 - (ACN Newswire via SEAPRWire.com) - Turnover and net profit increased at the same time, innovative pipeline continued to expand, and the synergy between its businesses became increasingly obvious .....China Medical System Limited (the "Company" or "CMS"), who has just released its annual results, has brought too many surprises to the market.In recent years, CMS has successfully completed its transformation from an "old CMS" driven by sales and promotion to a "new CMS" driven by innovative R&D by deepening its innovative pipeline and promoting the synergistic development of multiple business lines. Now, with its strength in business development and sales promotion, the innovative pipeline and new businesses continued to expand, which has become a powerful driving force to lift the Company's valuation ceiling.According to zhitongcaijing.com app, on March 16, CMS released its 2020 annual results. The financial report shows that the Company's overall performance achieved solid growth in 2020, with annual turnover up 14.4% y-o-y to RMB6.946 billion, net profit up 30.7% y-o-y to RMB2.556 billion.In fact, the Company's ability to grow against the odds in an en...

ACN Newswire
Read More

China Medical System (0867.HK) Acquires a Dermatology Specialty Company: A Tough Player the Race

indie
12 minutes

HONG KONG, Feb 5, 2021 - (ACN Newswire) - On February 1, China Medical System (0867.HK) announced that its subsidiary had acquired Luqa Ventures Co., Limited ("Luqa"), a dermatology specialty company. This acquisition expanded its product portfolio to include Luqa's dermatology products and marked the first foray into the medical aesthetic industry for China Medical System.Why medical aesthetics? What is the significance of this acquisition?1. Consolidating the Skin Management Business and Entering the Medical Aesthetic Market: Acquiring Luqa to Explore a New Growth EngineAccording to its official website, established in 2010, Luqa is an innovative enterprise with skin treatment and medical aesthetic solutions as its core business.Its founder, Mr. Luo Benwei, is experienced in medicine and was involved in Asia's skin management and medical aesthetic industry before establishing Luqa. In 2005, as Almirall's youngest international business development manager, Mr. Luo successfully drove the company's products into markets in Africa, the Middle East, West Asia and East Asia.China Medical System recognized Luqa's many advantages, including: its abundant overseas resources of medical ae...